The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimozato, O.
Right arrow Articles by Young, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimozato, O.
Right arrow Articles by Young, H. A.
The Journal of Immunology, 2002, 168: 1746-1752.
Copyright © 2002 by The American Association of Immunologists

Impaired NK Cell Development in an IFN-{gamma} Transgenic Mouse: Aberrantly Expressed IFN-{gamma} Enhances Hematopoietic Stem Cell Apoptosis and Affects NK Cell Differentiation1

Osamu Shimozato*, John R. Ortaldo*, Kristin L. Komschlies{dagger} and Howard A. Young2,*

* Laboratory of Experimental Immunology, Center for Cancer Research, and {dagger} Intramural Research Support Program, Science Applications International Corp.-Frederick, National Cancer Institute, Frederick, MD 21702

Aberrant expression of IFN-{gamma} has been demonstrated to cause a wide variety of alterations in cell function and development. Previously we reported that constitutive expression of IFN-{gamma} in bone marrow (BM) and thymus results in a total absence of B cells and a substantial decrease in the number of hematopoietic progenitor cells. In this study, we demonstrate a severe deficiency of NK1.1+CD3- cells in this transgenic mouse model. Compared with normal control littermates, we found a pronounced reduction of NK cells in IFN-{gamma} transgenic mouse spleen and liver despite maintenance of normal function. In addition, we observed a reduced number of BM cells in the IFN-{gamma} transgenic mouse despite normal expression of hematopoietic growth factors in the BM. Interestingly, these cells were less responsive to stem cell factor (SCF) despite c-kit expression on hematopoietic stem cells (HSCs). We observed that addition of exogenous IFN-{gamma} inhibited proliferation of HSCs and differentiation of NK precursors from HSCs in normal mice in response to SCF, IL-7, fms-like tyrosine kinase 3 ligand, and IL-15. Furthermore, we found that HSCs express the IFN-{gamma}R{alpha} subunit and undergo apoptosis in response to exogenous IFN-{gamma}. Thus, we have demonstrated the occurrence of a severe deficiency of NK cells and lower numbers of BM cells in an IFN-{gamma} transgenic mouse model. Furthermore, because exogenous IFN-{gamma} affects the responsiveness to hematopoietic growth factors such as SCF in vitro, our results indicate that chronic expression of IFN-{gamma} in vivo leads to widespread immune system defects, including alterations in NK cell differentiation.




This article has been cited by other articles:


Home page
J. Immunol.Home page
K. Nakagome, K. Okunishi, M. Imamura, H. Harada, T. Matsumoto, R. Tanaka, J.-i. Miyazaki, K. Yamamoto, and M. Dohi
IFN-{gamma} Attenuates Antigen-Induced Overall Immune Response in the Airway As a Th1-Type Immune Regulatory Cytokine
J. Immunol., July 1, 2009; 183(1): 209 - 220.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. Becknell, T. L. Hughes, A. G. Freud, B. W. Blaser, J. Yu, R. Trotta, H. C. Mao, M. L. Caligiuri de Jesus, M. Alghothani, D. M. Benson Jr, et al.
Hlx homeobox transcription factor negatively regulates interferon-{gamma} production in monokine-activated natural killer cells
Blood, March 15, 2007; 109(6): 2481 - 2487.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Yu, G. C. Sharp, and H. Braley-Mullen
Dual Roles for IFN-{gamma}, But Not for IL-4, in Spontaneous Autoimmune Thyroiditis in NOD.H-2h4 Mice
J. Immunol., October 1, 2002; 169(7): 3999 - 4007.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.